The challenge of implementing high-throughput technologies in clinical trials

Author： Mocellin Simone   Marincola Francesco M  

Publisher： Future Medicine

ISSN： 1462-2416

Source： Pharmacogenomics, Vol.6, Iss.4, 2005-06, pp. : 435-439

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Related content

The role of high-throughput technologies in clinical cancer genomics

By Idris Saad F   Ahmad Saif S   Scott Michael A   Vassiliou George S   Hadfield James  

Expert Review of Molecular Diagnostics, Vol. 13, Iss. 2, 2013-03 ,pp. : 167-181

Informa Healthcare

Access to resources Recommend Favorite

New technologies for high-throughput analysis

By Liu Edison T  

Pharmacogenomics, Vol. 6, Iss. 5, 2005-07 ,pp. : 469-471

Future Medicine

Access to resources Recommend Favorite

High-Throughput Screening Technologies for Botulinum Neurotoxins

By  

Current Topics in Medicinal Chemistry, Vol. 14, Iss. 18, 2014-09 ,pp. : 2062-2080

Bentham Science Publishers

Access to resources Recommend Favorite

Exploiting High-Throughput Ion Channel Screening Technologies in Integrated Drug Discovery

By  

Current Pharmaceutical Design, Vol. 12, Iss. 4, 2006-02 ,pp. : 397-406

Bentham Science Publishers

Access to resources Recommend Favorite

High Throughput Genotyping Technologies for Pharmacogenomics

By Brennan M.D.  

American Journal of PharmacoGenomics, Vol. 1, Iss. 4, 2001-01 ,pp. : 295-302

Adis International

Access to resources Recommend Favorite